-
Single, high-dose vaccine could provide better protection against cholera outbreaks, new research sh
pharmafile
December 13, 2017
A team at UMSOM has been evaluating the efficacy of a single high-dose live vaccine in the treatment of cholera rather than the traditional two-dose inactivated vaccine approach, hoping to more successfully protect the recent massive outbreak.
-
Gene-based Zika vaccine is safe and induces immune response in healthy adults
worldpharmanews
December 07, 2017
Results from two Phase I clinical trials show that experimental Zika vaccines developed by government scientists at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health are safe and induce immune responses in heal
-
Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease
europeanpharmaceuticalreview
November 27, 2017
Researchers have discovered that a virus-like particle vaccine can prime the body’s immune response and prevent the severe respiratory diseases…
-
Merck will delay filing Ebola vaccine for approval until 2018, company confirms
fiercepharma
November 22, 2017
Despite a frantic effort to rush Ebola vaccines through testing during a deadly epidemic, Merck & Co. will fall short of its goal to file its candidate for FDA approval this year, the company confirmed Tuesday.
-
FDA clears first new hep B vaccine in 25 years
pharmatimes
November 14, 2017
The US Food and Drug Administration is allowing onto the market the first new hepatitis B vaccine in more than 25 years with the approval of Dynavax’ Heplisav-B.
-
Researchers design a vaccine for Streptococcus
biospectrumasia
November 07, 2017
The researchers say that a vaccine which was 80% effective and reached 90% of women could potentially prevent 231,000 infant and maternal cases of disease.
-
4-in-1 vaccine may provide lifelong protection against influenza
europeanpharmaceuticalreview
November 06, 2017
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza…
-
China approves domestic Ebola vaccine
biospectrumasia
October 27, 2017
The newly approved vaccine is superior to the currently available vaccines in terms of the stability.
-
GSK's shingles vaccine scores US approval
pharmafile
October 24, 2017
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention of the disease in patients aged 50 or older.
-
New vaccine offers hope for pneumonia
europeanpharmaceuticalreview
October 23, 2017
Scientists are developing a vaccine by targeting strains of S. pneumoniae…